Researchers Jason Gill and Paul Turner will discuss their work on bacteriophage therapy to treat drug resistant bacterial infections.

Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!

New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.

Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.

The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.

The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.

Fungal researcher Christina Cuomo discusses the spread of infections plaguing hospitals across the world.

The parasite that causes malaria has evolved to evade many of the drugs that researchers have developed to fight the tropical disease.

Plasmodium falciparum has shown an ability to evade everything we throw at it, most recently artemisinin-based combination therapies, today’s front-line treatment.